WVE
Wave Life Sciences, Inc.
Company overview
- Market capitalization
- $723.17M
- Employees
- 317
- Latest publication
- 2026-09-29
About Wave Life Sciences, Inc.
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; WVE-007, a GalNAc-conjugated small interfering RNA designed to silence INHBE mRNA targeting obesity; WVE-008, a GalNAc-conjugated RNA editing oligonucleotide for the treatment of liver disease; WVE-N531, an exon splicing oligonucleotide for the treatment of Duchenne muscular dystrophy; and WVE-003, an allele-selective oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD | Q3 20232023-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,272,000USD | 38,246,000USD | 7,608,000USD | 83,748,000USD | -7,676,000USD | 19,692,000USD | 12,538,000USD | 49,214,000USD |
| Research Development | 51,293,000USD | 47,440,000USD | 45,874,000USD | 44,645,000USD | 41,197,000USD | 40,393,000USD | 33,447,000USD | 31,642,000USD |
| General And Administrative Expenses | 24,781,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 76,074,000USD | 69,544,000USD | 63,961,000USD | 60,781,000USD | 56,239,000USD | 54,689,000USD | 46,996,000USD | 13,128,000USD |
| Operating Income | -73,802,000USD | -31,298,000USD | -56,353,000USD | 22,967,000USD | -63,915,000USD | -34,997,000USD | -34,458,000USD | 4,444,000USD |
| Total Other Income Expense Net | 4,447,000USD | 5,211,000USD | 2,501,000USD | 6,286,000USD | 2,135,000USD | 2,074,000USD | 2,900,000USD | 3,484,999USD |
| Interest Income | 4,722,000USD | 5,291,000USD | 2,177,000USD | — | 1,798,000USD | 2,092,000USD | 2,535,000USD | — |
| Income Before Tax | -69,355,000USD | -26,087,000USD | -53,852,000USD | 29,253,000USD | -61,780,000USD | -32,923,000USD | -31,558,000USD | 7,928,999USD |
| Income Tax Expense | 0USD | — | — | — | — | -1USD | -1USD | 676,999USD |
| Net Income | -69,355,000USD | -26,087,000USD | -53,852,000USD | 29,253,000USD | -61,780,000USD | -32,923,000USD | -31,558,000USD | 7,252,000USD |
| Gross Profit | — | 38,246,000USD | 7,608,000USD | 83,748,000USD | -7,676,000USD | 19,692,000USD | 12,538,000USD | 17,572,000USD |
| Selling General Administrative | — | 22,104,000USD | 18,087,000USD | 16,136,000USD | 15,042,000USD | 14,296,000USD | 13,549,000USD | 13,128,000USD |
| Net Interest Income | — | 5,291,000USD | 2,177,000USD | — | 1,798,000USD | 2,092,000USD | 2,535,000USD | — |
| Tax Provision | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | -677,000USD |
| Net Income From Continuing Ops | — | -26,087,000USD | -53,852,000USD | 29,253,000USD | -61,780,000USD | -32,923,000USD | -31,558,000USD | 7,252,000USD |
| Ebit | — | -26,087,000USD | -53,852,000USD | 29,253,000USD | -61,780,000USD | -32,923,000USD | -31,558,000USD | 7,928,999USD |
| Ebitda | — | -23,782,000USD | -51,622,000USD | 31,409,000USD | -59,622,000USD | -30,751,000USD | -29,381,000USD | 9,125,999USD |
| Depreciation And Amortization | — | 2,305,000USD | 2,230,000USD | 2,156,000USD | 2,158,000USD | 2,172,000USD | 2,177,000USD | 1,197,000USD |
| Reconciled Depreciation | — | 2,305,000USD | 2,230,000USD | 2,156,000USD | 2,158,000USD | 2,172,000USD | 2,177,000USD | 2,264,000USD |
| Cost Of Revenue | — | — | — | 65,732,000USD | 2,158,000USD | 2,172,000USD | 2,177,000USD | 31,642,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | — | -31,642,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 108,302,000USD | 113,305,000USD | 3,649,000USD | 40,964,000USD | 14,414,000USD | 3,704,000USD | 1,485,000USD | 152,000USD |
| Cost Of Revenue | 8,663,000USD | 9,206,000USD | 10,114,000USD | 121,875,000USD | 134,428,000USD | 79,309,000USD | 393,000USD | 9,057,000USD |
| Gross Profit | 108,302,000USD | 113,305,000USD | 3,649,000USD | 40,964,000USD | -120,014,000USD | -75,605,000USD | 1,092,000USD | -8,905,000USD |
| Research Development | 159,682,000USD | 130,009,000USD | 115,856,000USD | 121,875,000USD | 134,428,000USD | 79,309,000USD | 40,818,000USD | 9,057,000USD |
| Selling General Administrative | 59,023,000USD | 51,292,000USD | 50,513,000USD | 46,105,000USD | 39,509,000USD | 26,975,000USD | 15,994,000USD | 10,393,000USD |
| Total Operating Expenses | 218,705,000USD | 181,301,000USD | 166,369,000USD | 167,980,000USD | 173,937,000USD | 106,284,000USD | 56,812,000USD | 19,450,000USD |
| Operating Income | -110,403,000USD | -67,996,000USD | -162,720,000USD | -127,016,000USD | -159,523,000USD | -102,580,000USD | -55,327,000USD | -19,298,000USD |
| Income Before Tax | -97,008,000USD | -58,190,000USD | -161,142,000USD | -122,449,000USD | -146,584,000USD | -101,327,000USD | -54,785,000USD | -19,156,000USD |
| Tax Provision | 0USD | -677,000USD | 681,000USD | -204,000USD | 69,000USD | 708,000USD | 616,000USD | 44,000USD |
| Net Income | -97,008,000USD | -57,513,000USD | -161,823,000USD | -122,245,000USD | -146,653,000USD | -102,035,000USD | -55,401,000USD | -19,200,000USD |
| Net Income From Continuing Ops | -97,008,000USD | -57,513,000USD | -161,823,000USD | -122,245,000USD | -146,653,000USD | -102,035,000USD | -55,401,000USD | -19,200,000USD |
| Ebit | -97,008,000USD | -58,190,000USD | -162,720,000USD | -122,449,000USD | -159,523,000USD | -102,391,000USD | -55,720,000USD | -19,156,000USD |
| Ebitda | -88,345,000USD | -48,984,000USD | -152,606,000USD | -112,614,000USD | -153,942,000USD | -100,236,000USD | -54,936,000USD | -18,562,000USD |
| Depreciation And Amortization | 8,663,000USD | 9,206,000USD | 10,114,000USD | 9,835,000USD | 5,581,000USD | 2,155,000USD | 784,000USD | 594,000USD |
| Reconciled Depreciation | 8,663,000USD | 9,206,000USD | 10,114,000USD | 9,835,000USD | 5,581,000USD | 2,155,000USD | — | — |
| Total Other Income Expense Net | 13,395,000USD | 9,806,000USD | 1,578,000USD | 4,567,000USD | 12,939,000USD | 1,253,000USD | 542,000USD | 142,000USD |
| Income Tax Expense | — | -677,000USD | 681,000USD | -204,000USD | 69,000USD | 708,000USD | 616,000USD | 44,000USD |
| Interest Income | — | — | 1,571,000USD | — | 3,390,000USD | 1,584,000USD | 592,000USD | 86,000USD |
| Interest Expense | — | — | 1,578,000USD | 14,432,000USD | 22,000USD | 6,000USD | 337,000USD | 86,000USD |
| Net Interest Income | — | — | 1,571,000USD | — | 22,000USD | 6,000USD | 337,000USD | — |
| Non Operating Income Net Other | — | — | 1,578,000USD | 4,567,000USD | 12,917,000USD | 1,247,000USD | 205,000USD | 56,000USD |
| Net Income Applicable To Common Shares | — | — | -161,823,000USD | -122,245,000USD | -146,653,000USD | -101,980,000USD | -55,660,000USD | -19,200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 558,321,000USD | 583,544,000USD | 638,499,000USD | 241,378,000USD | 252,355,000USD | 288,343,000USD | 352,207,000USD | 358,504,000USD |
| Cash And Equivalents | 368,008,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 507,508,000USD | 561,272,000USD | 614,814,000USD | 215,488,000USD | 223,556,000USD | 257,976,000USD | 320,394,000USD | 324,515,000USD |
| Other Current Assets | 3,897,000USD | 16,681,000USD | 11,470,000USD | 9,270,000USD | 13,458,000USD | 14,901,000USD | 16,894,000USD | 13,567,000USD |
| Other Non Current Assets | 667,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 104,801,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 50,815,000USD | 49,831,000USD | 95,065,000USD | 85,896,000USD | 87,408,000USD | 87,367,000USD | 110,953,000USD | 170,728,000USD |
| Total Stockholder Equity | 453,520,000USD | 511,730,000USD | 526,231,000USD | 124,549,000USD | 139,266,000USD | 171,803,000USD | 209,515,000USD | 149,514,000USD |
| Total Equity Including Noncontrolling Interest | 453,520,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 8,703,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 13,904,000USD | — | — | — | — | — | — | — |
| Net Receivables | 888,000USD | 0USD | 1,276,000USD | 10,000,000USD | 1,617,000USD | 1,422,000USD | 1,422,000USD | 0USD |
| Property Plant Equipment Net | 46,331,000USD | 18,071,000USD | 19,863,000USD | 22,072,000USD | 24,287,000USD | 26,147,000USD | 27,998,000USD | 30,047,000USD |
| Accounts Payable | 20,362,000USD | 19,064,000USD | 15,700,000USD | 14,490,000USD | 14,664,000USD | 14,358,000USD | 16,262,000USD | 12,781,000USD |
| Short Term Debt | 3,508,000USD | 8,328,000USD | 8,361,000USD | 8,394,000USD | 8,136,000USD | 7,884,000USD | 7,638,000USD | 7,398,000USD |
| Common Stock | 1,627,209,000USD | 1,626,879,000USD | 1,616,478,000USD | 1,223,721,000USD | 1,191,029,000USD | 1,179,336,000USD | 1,175,181,000USD | 1,139,714,000USD |
| Retained Earnings | -1,421,678,000USD | -1,352,323,000USD | -1,326,236,000USD | -1,273,057,000USD | -1,219,205,000USD | -1,168,736,000USD | -1,121,858,000USD | -1,151,111,000USD |
| Accumulated Other Comprehensive Income | -172,000USD | -254,000USD | -250,000USD | -190,000USD | -161,000USD | -204,000USD | -262,000USD | -159,000USD |
| Total Liab | — | 71,814,000USD | 112,268,000USD | 116,829,000USD | 113,089,000USD | 116,540,000USD | 142,692,000USD | 208,990,000USD |
| Other Current Liab | — | 13,043,000USD | 26,564,000USD | 16,487,000USD | 13,026,000USD | 7,813,000USD | 21,081,000USD | 14,642,000USD |
| Capital Stock | — | 1,626,879,000USD | 1,616,478,000USD | 1,223,721,000USD | 1,191,029,000USD | 1,179,336,000USD | 1,175,181,000USD | 1,139,714,000USD |
| Cash | — | 544,591,000USD | 602,068,000USD | 196,218,000USD | 208,481,000USD | 243,075,000USD | 302,078,000USD | 310,948,000USD |
| Cash And Short Term Investments | — | 544,591,000USD | 602,068,000USD | 196,218,000USD | 208,481,000USD | 243,075,000USD | 302,078,000USD | 310,948,000USD |
| Current Deferred Revenue | — | 9,396,000USD | 44,440,000USD | 46,525,000USD | 51,582,000USD | 57,312,000USD | 65,972,000USD | 135,907,000USD |
| Net Debt | — | -528,876,000USD | -584,302,000USD | -176,446,000USD | -186,770,000USD | -219,476,000USD | -276,674,000USD | -283,778,000USD |
| Short Long Term Debt Total | — | 15,715,000USD | 17,766,000USD | 19,772,000USD | 21,711,000USD | 23,599,000USD | 25,404,000USD | 27,170,000USD |
| Property Plant Equipment Gross | — | 68,423,000USD | 69,385,000USD | 70,827,000USD | 72,205,000USD | 73,174,000USD | 74,327,000USD | 75,537,000USD |
| Common Stock Shares Outstanding | — | 200,167,869shares | 180,152,207shares | 167,739,208shares | 163,987,640shares | 162,527,026shares | 172,290,361shares | 132,563,000shares |
| Non Current Assets Total | — | 22,272,000USD | 23,685,000USD | 25,890,000USD | 28,799,000USD | 30,367,000USD | 31,813,000USD | 33,989,000USD |
| Non Current Liabilities Total | — | 21,982,999USD | 17,203,000USD | 30,933,000USD | 25,681,000USD | 29,173,000USD | 31,739,000USD | 38,262,000USD |
| Non Currrent Assets Other | — | 386,000USD | 16,000USD | 3,818,000USD | 4,512,000USD | 4,220,000USD | 3,815,000USD | 196,000USD |
| Net Working Capital | — | 511,441,000USD | 519,749,000USD | 129,592,000USD | 136,148,000USD | 170,609,000USD | 209,441,000USD | 153,787,000USD |
| Unclassified Non Current Assets | — | 3,815,000USD | 3,806,000USD | — | — | — | — | 3,746,000USD |
| Unclassified Non Current Liabilities | — | 21,982,999USD | 17,203,000USD | 30,933,000USD | 25,681,000USD | 29,173,000USD | 31,739,000USD | 38,262,000USD |
| Unclassified Equity | — | -1,389,451,000USD | -1,380,239,000USD | -1,049,646,000USD | -1,023,426,000USD | -1,017,929,000USD | -1,018,727,000USD | -978,644,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 638,499,000USD | 352,207,000USD | 274,949,000USD | 146,386,000USD | 207,007,000USD | 279,238,000USD | 284,250,000USD | 295,940,000USD |
| Other Current Assets | 11,470,000USD | 16,894,000USD | 13,936,000USD | 10,040,000USD | 12,000,000USD | 15,545,000USD | 18,315,000USD | 17,454,000USD |
| Total Liab | 112,268,000USD | 142,692,000USD | 235,319,000USD | 191,477,000USD | 174,509,000USD | 188,586,000USD | 212,644,000USD | 222,592,000USD |
| Total Stockholder Equity | 526,231,000USD | 209,515,000USD | 39,630,000USD | -45,091,000USD | 32,498,000USD | 90,652,000USD | 71,606,000USD | 73,348,000USD |
| Other Current Liab | 26,564,000USD | 21,081,000USD | 16,828,000USD | 17,552,000USD | 14,861,000USD | 11,971,000USD | 16,185,000USD | 13,695,000USD |
| Common Stock | 1,616,478,000USD | 1,175,181,000USD | 935,367,000USD | 802,833,000USD | 749,851,000USD | 694,085,000USD | 539,547,000USD | 375,148,000USD |
| Capital Stock | 1,616,478,000USD | 1,175,181,000USD | 935,367,000USD | 802,833,000USD | 749,851,000USD | 694,085,000USD | 539,547,000USD | 375,148,000USD |
| Retained Earnings | -1,326,236,000USD | -1,121,858,000USD | -1,024,850,000USD | -967,337,000USD | -805,514,000USD | -683,269,000USD | -533,359,000USD | -339,721,000USD |
| Cash | 602,068,000USD | 302,078,000USD | 200,351,000USD | 88,497,000USD | 150,564,000USD | 184,497,000USD | 147,161,000USD | 174,819,000USD |
| Cash And Short Term Investments | 602,068,000USD | 302,078,000USD | 200,351,000USD | 88,497,000USD | 150,564,000USD | 184,497,000USD | 147,161,000USD | 174,819,000USD |
| Total Current Assets | 614,814,000USD | 320,394,000USD | 235,373,000USD | 98,537,000USD | 162,564,000USD | 230,042,000USD | 185,476,000USD | 202,273,000USD |
| Total Current Liabilities | 95,065,000USD | 110,953,000USD | 186,440,000USD | 71,521,000USD | 64,201,000USD | 121,040,000USD | 118,153,000USD | 130,041,000USD |
| Current Deferred Revenue | 44,440,000USD | 65,972,000USD | 150,059,000USD | 31,558,000USD | 37,098,000USD | 91,560,000USD | 89,652,000USD | 100,945,000USD |
| Net Debt | -584,302,000USD | -276,674,000USD | -168,233,000USD | -50,883,000USD | -120,648,000USD | -155,192,000USD | -114,614,000USD | -164,416,000USD |
| Short Term Debt | 8,361,000USD | 7,638,000USD | 6,714,000USD | 5,496,000USD | 4,961,000USD | 3,714,000USD | 3,243,000USD | 2,312,000USD |
| Short Long Term Debt Total | 17,766,000USD | 25,404,000USD | 32,118,000USD | 37,614,000USD | 29,916,000USD | 29,305,000USD | 32,547,000USD | 10,403,000USD |
| Net Receivables | 1,276,000USD | 1,422,000USD | 21,086,000USD | 0USD | 0USD | 30,000,000USD | 20,000,000USD | 10,000,000USD |
| Accounts Payable | 15,700,000USD | 16,262,000USD | 12,839,000USD | 16,915,000USD | 7,281,000USD | 13,795,000USD | 9,073,000USD | 13,089,000USD |
| Property Plant Equipment Net | 19,863,000USD | 27,998,000USD | 35,721,000USD | 44,127,000USD | 40,644,000USD | 45,430,000USD | 54,469,000USD | 39,931,000USD |
| Property Plant Equipment Gross | 69,385,000USD | 74,327,000USD | 78,430,000USD | 44,127,000USD | 40,644,000USD | 45,430,000USD | 54,469,000USD | 39,931,000USD |
| Accumulated Other Comprehensive Income | -250,000USD | -262,000USD | -124,000USD | -29,000USD | 181,000USD | 389,000USD | 267,000USD | 153,000USD |
| Common Stock Shares Outstanding | 168,649,795shares | 138,277,468shares | 106,097,268shares | 78,855,810shares | 51,825,566shares | 39,227,618shares | 33,866,487shares | 28,970,404shares |
| Non Current Assets Total | 23,685,000USD | 31,813,000USD | 39,576,000USD | 47,849,000USD | 44,443,000USD | 49,196,000USD | 98,774,000USD | 93,667,000USD |
| Non Current Liabilities Total | 17,203,000USD | 31,739,000USD | 48,879,000USD | 119,956,000USD | 110,308,000USD | 67,546,000USD | 94,491,000USD | 92,551,000USD |
| Non Currrent Assets Other | 16,000USD | 3,815,000USD | 3,855,000USD | 3,722,000USD | 3,799,000USD | 115,000USD | 10,658,000USD | 111,000USD |
| Net Working Capital | 519,749,000USD | 209,441,000USD | 48,933,000USD | 27,016,000USD | 98,363,000USD | 109,002,000USD | 67,323,000USD | 72,232,000USD |
| Unclassified Non Current Assets | 3,806,000USD | — | — | -3,722,000USD | -3,799,000USD | — | -10,658,000USD | -50,111,000USD |
| Unclassified Non Current Liabilities | 17,203,000USD | 31,739,000USD | 48,879,000USD | -72,090,000USD | -69,605,000USD | -41,955,000USD | 27,583,000USD | — |
| Unclassified Equity | -1,380,239,000USD | -1,018,727,000USD | -806,130,000USD | -683,391,000USD | -661,871,000USD | -614,638,000USD | -474,396,000USD | -337,380,000USD |
| Inventory | — | — | 1USD | — | — | 10,434,000USD | 9,626,000USD | — |
| Other Liab | — | — | — | 79,964,000USD | 77,479,000USD | 41,955,000USD | 65,187,000USD | 84,677,000USD |
| Other Assets | — | — | — | 3,722,000USD | 3,799,000USD | 3,766,000USD | 44,305,000USD | 53,736,000USD |
| Non Current Liabilities Other | — | — | — | 112,082,000USD | 102,434,000USD | 67,546,000USD | 1,721,000USD | 2,142,000USD |
| Net Tangible Assets | — | — | — | -37,217,000USD | 40,372,000USD | 90,652,000USD | 63,732,000USD | 73,348,000USD |
| Unclassified Current Assets | — | — | — | — | — | -10,434,000USD | -9,626,000USD | — |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 5,132,000USD |
| Long Term Investments | — | — | — | — | — | — | — | 50,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -26,087,000USD | -53,179,000USD | -53,852,000USD | -50,469,000USD | -46,878,000USD | 29,253,000USD | -61,780,000USD | -32,923,000USD |
| Depreciation | 1,464,000USD | 2,262,000USD | 2,230,000USD | 2,196,000USD | 2,164,000USD | 2,156,000USD | 2,158,000USD | 2,172,000USD |
| Stock Based Compensation | 9,063,000USD | -17,621,000USD | 6,472,000USD | 6,196,000USD | 4,953,000USD | 3,244,000USD | 3,531,000USD | 3,485,000USD |
| Other Non Cash Items | 841,000USD | 8,591,034USD | -25,873,000USD | 1,740,000USD | — | — | — | 3,380,070USD |
| Change To Account Receivables | 1,276,000USD | 8,901,775USD | -8,383,000USD | -1,617,000USD | 1,422,000USD | -1,422,000USD | 1,290,000USD | -1,382,700USD |
| Change In Working Capital | -44,834,000USD | 10,202,677USD | 484,000USD | -3,935,000USD | -23,278,000USD | -78,301,000USD | 9,613,000USD | -202,000USD |
| Total Cash From Operating Activities | -59,553,000USD | -32,123,289USD | -44,666,000USD | -46,012,000USD | -63,039,000USD | -43,648,000USD | -46,478,000USD | -27,468,000USD |
| Capital Expenditures | -438,000USD | -10,009USD | -248,000USD | -306,000USD | -165,000USD | -86,000USD | -383,000USD | -52,000USD |
| Free Cash Flow | -59,991,000USD | -32,113,280USD | -44,914,000USD | -46,318,000USD | -63,204,000USD | -43,734,000USD | -46,861,000USD | -27,520,000USD |
| Total Cashflows From Investing Activities | -438,000USD | 10,012USD | -248,000USD | -306,000USD | -165,000USD | -86,000USD | -383,000USD | -52,000USD |
| Total Cash From Financing Activities | 2,527,000USD | 442,632,737USD | 32,692,000USD | 11,693,000USD | 4,155,000USD | 34,981,000USD | 203,746,000USD | 653,000USD |
| Issuance Of Capital Stock | 0USD | 429,913,000USD | 30,212,000USD | 11,099,000USD | 1,262,000USD | 32,945,000USD | 188,646,000USD | 547,000USD |
| Change In Cash | -57,468,000USD | 405,850,000USD | -12,251,000USD | -34,582,000USD | -58,991,000USD | -8,856,000USD | 157,005,000USD | -26,948,000USD |
| Begin Period Cash Flow | 605,874,000USD | 196,218,000USD | 212,265,000USD | 246,847,000USD | 305,838,000USD | 314,694,000USD | 157,689,000USD | 184,637,000USD |
| End Period Cash Flow | 548,406,000USD | 602,068,000USD | 200,014,000USD | 212,265,000USD | 246,847,000USD | 305,838,000USD | 314,694,000USD | 157,689,000USD |
| Other Cashflows From Financing Activities | 2,527,000USD | 439,695,000USD | 2,480,000USD | 594,000USD | 2,893,000USD | 2,036,000USD | 15,100,000USD | 106,000USD |
| Other Cashflows From Investing Activities | — | -708,988USD | — | — | -938,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | 17,621,000USD | 25,873,000USD | -1,740,000USD | — | — | — | -3,380,070USD |
| Unclassified Financing Cash Flow | — | -426,975,263USD | — | — | — | — | — | — |
| Investments | — | — | -248,000USD | -306,000USD | -165,000USD | -86,000USD | -383,000USD | -52,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | 1,103,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -204,378,000USD | -97,008,000USD | -57,513,000USD | -161,823,000USD | -122,245,000USD | -149,910,000USD | -193,638,000USD | -146,653,000USD |
| Depreciation | 8,852,000USD | 8,663,000USD | 9,206,000USD | 10,114,000USD | 9,835,000USD | 9,983,000USD | 9,201,000USD | 5,581,000USD |
| Stock Based Compensation | 24,973,000USD | 13,141,000USD | 9,795,000USD | 17,194,000USD | 16,407,000USD | 14,296,000USD | 19,509,000USD | 15,596,000USD |
| Other Non Cash Items | 24,973,000USD | -75,204,000USD | -24,847,000USD | 12,000USD | 12,644,000USD | 9,145,000USD | 31,408,000USD | 183,000USD |
| Change To Account Receivables | 146,000USD | 19,664,000USD | -21,086,000USD | 22,500,000USD | 30,000,000USD | 20,000,000USD | 10,000,000USD | -59,000,000USD |
| Change In Working Capital | -16,940,000USD | -75,822,000USD | 19,081,000USD | 6,722,000USD | 7,010,000USD | 9,649,000USD | -23,303,000USD | 102,387,000USD |
| Total Cash From Operating Activities | -187,493,000USD | -151,026,000USD | -19,431,000USD | -127,781,000USD | -88,993,000USD | -115,982,000USD | -188,231,000USD | -22,862,000USD |
| Capital Expenditures | -718,000USD | -938,000USD | -1,115,000USD | -1,361,000USD | -560,000USD | -1,338,000USD | -3,918,000USD | -9,938,000USD |
| Free Cash Flow | -187,493,000USD | -151,964,000USD | -20,546,000USD | -129,142,000USD | -89,553,000USD | -117,320,000USD | -192,149,000USD | -32,800,000USD |
| Total Cashflows From Investing Activities | -718,000USD | -938,000USD | -1,115,000USD | -1,255,000USD | -560,000USD | -1,338,000USD | -3,918,000USD | -9,938,000USD |
| Total Cash From Financing Activities | 488,235,000USD | 253,890,000USD | 132,534,000USD | 67,188,000USD | 55,828,000USD | 154,538,000USD | 164,399,000USD | 65,094,000USD |
| Issuance Of Capital Stock | 472,486,000USD | 236,176,000USD | 131,277,000USD | 52,325,000USD | 54,970,000USD | 153,626,000USD | 161,792,000USD | 60,000,000USD |
| Change In Cash | 300,036,000USD | 101,788,000USD | 111,893,000USD | -62,058,000USD | -33,933,000USD | 37,340,000USD | -27,636,000USD | 32,331,000USD |
| Begin Period Cash Flow | 302,078,000USD | 204,050,000USD | 92,157,000USD | 154,215,000USD | 188,148,000USD | 150,808,000USD | 178,444,000USD | 146,113,000USD |
| End Period Cash Flow | 602,068,000USD | 305,838,000USD | 204,050,000USD | 92,157,000USD | 154,215,000USD | 188,148,000USD | 150,808,000USD | 178,444,000USD |
| Other Cashflows From Investing Activities | -718,000USD | -938,000USD | — | 106,000USD | — | — | -3,918,000USD | -9,938,000USD |
| Other Cashflows From Financing Activities | 488,235,000USD | 17,714,000USD | 1,257,000USD | 14,863,000USD | 858,000USD | 912,000USD | 2,607,000USD | 5,110,000USD |
| Unclassified Operating Cash Flow | -24,973,000USD | 75,204,000USD | 24,847,000USD | — | -12,644,000USD | -9,145,000USD | -31,408,000USD | — |
| Unclassified Financing Cash Flow | -472,486,000USD | — | — | -13,758,000USD | — | 58,970,000USD | -2,607,000USD | -5,110,000USD |
| Investments | — | -938,000USD | -1,115,000USD | -1,255,000USD | -560,000USD | -1,338,000USD | -3,918,000USD | -9,938,000USD |
| Unclassified Investing Cash Flow | — | 1,876,000USD | 1,115,000USD | 1,255,000USD | — | 1,338,000USD | 7,836,000USD | 19,876,000USD |
| Change To Liabilities | — | — | — | 12,229,000USD | -4,151,000USD | -344,000USD | -19,480,000USD | 11,323,000USD |
| Sale Purchase Of Stock | — | — | — | 66,083,000USD | 55,828,000USD | 94,656,000USD | 164,399,000USD | 65,110,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -61,848,000USD | -33,725,000USD | 37,218,000USD | — | 32,294,000USD |
| Change To Inventory | — | — | — | — | 2,041,000USD | 4,609,000USD | -5,454,000USD | -4,082,000USD |
| Net Borrowings | — | — | — | — | — | — | — | -16,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.